Sign inGet started

Lund-Hansen Torben

Insider CIK 1753134 · YMAB Sr. VP & CTO

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
YMAB Y-mAbs Therapeutics, Inc. M Exercise deriv2024-08-282024-08-3050,000— $0100,000SEC↗
YMAB Y-mAbs Therapeutics, Inc. M Exercise2024-08-282024-08-3050,000$4.38 $219.0K85,600SEC↗
YMAB Y-mAbs Therapeutics, Inc. S Sale2024-08-282024-08-3050,000$15.37 $768.5K35,600SEC↗
YMAB Y-mAbs Therapeutics, Inc. A Award deriv2024-01-182024-01-2235,700— $035,700SEC↗
YMAB Y-mAbs Therapeutics, Inc. A Award2024-01-182024-01-2217,800— $035,600SEC↗
YMAB Y-mAbs Therapeutics, Inc. A Award deriv2023-01-262023-01-3032,000— $032,000SEC↗
YMAB Y-mAbs Therapeutics, Inc. A Award deriv2023-01-172023-01-1935,700— $035,700SEC↗
YMAB Y-mAbs Therapeutics, Inc. A Award2023-01-172023-01-1917,800— $017,800SEC↗
YMAB Y-mAbs Therapeutics, Inc. A Award deriv2022-04-262022-04-2820,000— $020,000SEC↗
YMAB Y-mAbs Therapeutics, Inc. A Award deriv2021-12-142021-12-1632,000— $032,000SEC↗
YMAB Y-mAbs Therapeutics, Inc. A Award deriv2020-12-152020-12-1620,000— $020,000SEC↗
YMAB Y-mAbs Therapeutics, Inc. A Award deriv2019-12-102019-12-1120,000— $020,000SEC↗
YMAB Y-mAbs Therapeutics, Inc. A Award deriv2018-12-112018-12-1320,000— $020,000SEC↗